Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine have?
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine has 116 citations in the OpenAlex counts ScholarIQ stores.
When was Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine published?
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine has 2005 year in the ScholarIQ index.
What is the open-access status of Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine has closed oa status in the ScholarIQ index.
What is the DOI of Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?
The DOI for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is on the source record.
What is the PMID of Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?
The PMID for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is on the source record.
What is the OpenAlex record for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine?
The OpenAlex for Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine is on the source record.